Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 millionAdjusted EBITDA profitability of $1.0 million for Q3Acquisition of ExoDx business from Bio-Techne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback